MX9201635A - Derivados de indol y di hidro quinolina. - Google Patents

Derivados de indol y di hidro quinolina.

Info

Publication number
MX9201635A
MX9201635A MX9201635A MX9201635A MX9201635A MX 9201635 A MX9201635 A MX 9201635A MX 9201635 A MX9201635 A MX 9201635A MX 9201635 A MX9201635 A MX 9201635A MX 9201635 A MX9201635 A MX 9201635A
Authority
MX
Mexico
Prior art keywords
quinolina
hidro
indol
derivatives
hidro quinolina
Prior art date
Application number
MX9201635A
Other languages
English (en)
Inventor
Karnail Atwal
George C Rovnyak
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/760,030 external-priority patent/US5310932A/en
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of MX9201635A publication Critical patent/MX9201635A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
MX9201635A 1991-04-15 1992-04-09 Derivados de indol y di hidro quinolina. MX9201635A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68532391A 1991-04-15 1991-04-15
US07/760,030 US5310932A (en) 1991-04-15 1991-09-11 Chromanyl substituted indole potassium channel openers

Publications (1)

Publication Number Publication Date
MX9201635A true MX9201635A (es) 1992-10-01

Family

ID=27103556

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201635A MX9201635A (es) 1991-04-15 1992-04-09 Derivados de indol y di hidro quinolina.

Country Status (12)

Country Link
EP (1) EP0509762A1 (es)
JP (1) JPH05117233A (es)
CN (1) CN1065865A (es)
AU (1) AU658618B2 (es)
CA (1) CA2065499A1 (es)
FI (1) FI921666A7 (es)
HU (1) HUT62580A (es)
IL (1) IL101456A0 (es)
MX (1) MX9201635A (es)
NO (1) NO921491L (es)
NZ (1) NZ242321A (es)
PL (1) PL169610B1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
US5880137A (en) * 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
US6069153A (en) * 1998-05-12 2000-05-30 American Home Products Corporation Indenoindoles and benzocarbazoles as estrogenic agents
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
US6159959A (en) * 1999-05-06 2000-12-12 American Home Products Corporation Combined estrogen and antiestrogen therapy
JP2008531590A (ja) * 2005-02-24 2008-08-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ カリウムイオンチャンネル開口薬としての新規なキノリン誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88035A0 (en) * 1987-10-27 1989-06-30 American Home Prod Benzopyran derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI921666L (fi) 1992-10-16
JPH05117233A (ja) 1993-05-14
AU1484192A (en) 1992-10-22
NZ242321A (en) 1993-09-27
AU658618B2 (en) 1995-04-27
EP0509762A1 (en) 1992-10-21
HU9201260D0 (en) 1992-07-28
FI921666A7 (fi) 1992-10-16
HUT62580A (en) 1993-05-28
NO921491L (no) 1992-10-16
PL169610B1 (pl) 1996-08-30
PL294216A1 (en) 1992-10-19
IL101456A0 (en) 1992-12-30
CN1065865A (zh) 1992-11-04
FI921666A0 (fi) 1992-04-14
NO921491D0 (no) 1992-04-14
CA2065499A1 (en) 1992-10-16

Similar Documents

Publication Publication Date Title
NL350021I1 (nl) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- en 3-aryl-4-hydroxy-delta3-dihydrothiofenon-derivaten.
DK43193D0 (da) Indolderivater
NL300035I1 (nl) Gesubstitueerde thiahzolidinedionderivaten.
FI942395A7 (fi) Indolijohdannaiset
FI930208L (fi) Kinazolinderivat
FI935431A7 (fi) Kiantsoliinijohdannaisia
FI980341A7 (fi) 2-oksi-indolijohdannaisia
FI933037A7 (fi) Tiazolylvinylfenylderivat
FI941423A7 (fi) 17beta-substituoidut 4-atsa-5alfa-androstan-3-onijohdannaiset
FI906202A0 (fi) Obemannat disksystem.
FI921262L (fi) 4-aryltiazol- eller 4-arylimidazolderivat
NO961475L (no) Indol-derivater
DE69330497D1 (de) Chinazolin-derivate
FI20010214L (fi) Asyyliaminoindolijohdannaisia
DE69212058D1 (de) Indol-Derivate
ITMI912655A1 (it) Combinazione di estrusore-calandra.
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI20002460A7 (fi) 4-difenyylimetyylipiperidiinijohdannaisia
MX9205003A (es) Derivados novedosos de benzopirano.
NO922934D0 (no) Cykloheksan- og tetrahydropyranderivater
FI925774A7 (fi) Indolijohdannaiset
DE69313890D1 (de) 5-Aminoflavon-Derivate
MX9204370A (es) Derivados de pirazol.
FI912963A0 (fi) Hjaernverksamheten oekande pyrimidinylderivat.
FI930367L (fi) Puridinderivat